chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia
Clinical narrative: Chills; body aches; Joint pain worsening; This spontaneous case was reported by a health care professional and describes the occurrence of CHILLS (Chills), MYALGIA (body aches) and ARTHRALGIA (Joint pain worsening) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 2620A and 012620A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Codeine), Drug allergy (PROCAINE), Drug allergy (SULFAMETHOXAXOLE), Drug allergy (TRIMETHOPRIM), Asthma (Mild) since January 1995 and Osteoarthritis (has gotten increasingly worse this past year especially after vaccine) since November 2014. Concomitant products included METABOLIFE for Weight loss.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (body aches) and ARTHRALGIA (Joint pain worsening). On 07-Feb-2021, CHILLS (Chills) and MYALGIA (body aches) had resolved. At the time of the report, ARTHRALGIA (Joint pain worsening) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other Concomitant medications included Generic Voltarin  did not take prior or after second dose for a week.. No treatment information was reported. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-006503 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Significant follow up ADR was received patent demographics were added,product details were added batch no start and stop date ,events outcome was added,
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm; area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm) and VACCINATION SITE ERYTHEMA (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE WARMTH (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm) and VACCINATION SITE ERYTHEMA (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm) and VACCINATION SITE ERYTHEMA (area on her arm where the vaccine was give that has a 3-4 inch diameter round red area that is is warm) outcome was unknown.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site area Warm to the Touch; Injection site area started swelling, Little to itchy; Injection site area started swelling; Injection site area started swelling,kinda red,; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site area Warm to the Touch), VACCINATION SITE PRURITUS (Injection site area started swelling, Little to itchy), VACCINATION SITE SWELLING (Injection site area started swelling) and VACCINATION SITE ERYTHEMA (Injection site area started swelling,kinda red,) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site area Warm to the Touch), VACCINATION SITE PRURITUS (Injection site area started swelling, Little to itchy), VACCINATION SITE SWELLING (Injection site area started swelling) and VACCINATION SITE ERYTHEMA (Injection site area started swelling,kinda red,). At the time of the report, VACCINATION SITE WARMTH (Injection site area Warm to the Touch), VACCINATION SITE PRURITUS (Injection site area started swelling, Little to itchy), VACCINATION SITE SWELLING (Injection site area started swelling) and VACCINATION SITE ERYTHEMA (Injection site area started swelling,kinda red,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Vaccination site swelling
Clinical narrative: Bruising in the armpit.; Swollen armpit; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruising in the armpit.) and VACCINATION SITE SWELLING (Swollen armpit) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026b21A and 027a21a) for COVID-19 vaccination.     Concurrent medical conditions included Lumbar radiculopathy (ongoing muscle, coordination loss in legs) since 2014. Concomitant products included SPIRONOLACTONE for Blood pressure high, LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]) for Diarrhea, ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE (PREMPRO) for HRT, NALTREXONE for Nerve injury.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced CONTUSION (Bruising in the armpit.) and VACCINATION SITE SWELLING (Swollen armpit). On 22-Apr-2021, CONTUSION (Bruising in the armpit.) and VACCINATION SITE SWELLING (Swollen armpit) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Additional information received On 03-May-2021: VAERS Form. Patient demographics, first dose details, event outcome was added.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid-19) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Patient's medical history included No Adverse event.  The patient's past medical history included SARS-CoV-2 infection.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced COVID-19 (Tested positive for Covid-19). In April 2021, COVID-19 (Tested positive for Covid-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported. Patient shown the symptoms include fever, feeling really sick, and fatigue. All are resolved except Fatigue. Treatment information not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Apr-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Non-significant follow up appended
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst, Vomiting
Clinical narrative: Flu-like symptoms that had been gradually worsening day by day; Cough; Chest congestion; Difficulty breathing; Head has been hurting a lot like sinus congestion,; feeling tremendously thirsty; Loss of appetite; Loss of memory; Terrible taste in mouth- sour and bitter; Feeling more depressed than normal; somnolence and wanting to sleep all day; Feeling very down; Very anxious; Trouble remembering; Very tired; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu-like symptoms that had been gradually worsening day by day), COUGH (Cough), CHEST PAIN (Chest congestion), DYSPNOEA (Difficulty breathing) and SINUS CONGESTION (Head has been hurting a lot like sinus congestion,) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), NITROGLYCERIN, METFORMIN, LOSARTAN, GABAPENTIN, FAMOTIDINE, ATORVASTATIN and LINACLOTIDE (LINZESS) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). On 31-Mar-2021, the patient experienced INFLUENZA (Flu-like symptoms that had been gradually worsening day by day), COUGH (Cough), CHEST PAIN (Chest congestion), DYSPNOEA (Difficulty breathing), SINUS CONGESTION (Head has been hurting a lot like sinus congestion,), THIRST (feeling tremendously thirsty), DECREASED APPETITE (Loss of appetite), AMNESIA (Loss of memory), DYSGEUSIA (Terrible taste in mouth- sour and bitter), DEPRESSION (Feeling more depressed than normal), SOMNOLENCE (somnolence and wanting to sleep all day), DEPRESSED MOOD (Feeling very down), ANXIETY DISORDER (Very anxious), MEMORY IMPAIRMENT (Trouble remembering) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NITROGLYCERIN for Chest pain, at an unspecified dose and frequency. On 31-Mar-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, INFLUENZA (Flu-like symptoms that had been gradually worsening day by day), COUGH (Cough), CHEST PAIN (Chest congestion), DYSPNOEA (Difficulty breathing), SINUS CONGESTION (Head has been hurting a lot like sinus congestion,), THIRST (feeling tremendously thirsty), DECREASED APPETITE (Loss of appetite), AMNESIA (Loss of memory), DYSGEUSIA (Terrible taste in mouth- sour and bitter), DEPRESSION (Feeling more depressed than normal), SOMNOLENCE (somnolence and wanting to sleep all day), DEPRESSED MOOD (Feeling very down), ANXIETY DISORDER (Very anxious), MEMORY IMPAIRMENT (Trouble remembering) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications included depression medicines.  Treatment information included hydration.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Lymphadenopathy, Pain in extremity
Clinical narrative: Severe pain in the arm; Felt trouble breathing; Swelling of the lymph nodes around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe pain in the arm), DYSPNOEA (Felt trouble breathing) and LYMPHADENOPATHY (Swelling of the lymph nodes around injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Severe pain in the arm), DYSPNOEA (Felt trouble breathing) and LYMPHADENOPATHY (Swelling of the lymph nodes around injection site). At the time of the report, PAIN IN EXTREMITY (Severe pain in the arm), DYSPNOEA (Felt trouble breathing) and LYMPHADENOPATHY (Swelling of the lymph nodes around injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: very tired; Chills; fever of 102.5 degree F.; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (fever of 102.5 degree F.) and FATIGUE (very tired) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (fever of 102.5 degree F.). On 11-Apr-2021, the patient experienced FATIGUE (very tired). On 10-Apr-2021, CHILLS (Chills) had resolved. At the time of the report, PYREXIA (fever of 102.5 degree F.) and FATIGUE (very tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Body temperature: 102.5 f (High) Fever of 102.5 degree F..         This case was linked to MOD-2021-074105 (Patient Link).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Lymphadenopathy, Peripheral swelling, Rash, Swelling
Clinical narrative: Shoe was swollen up/swelling is in his lower left: ankle, foot, and leg; Pelvis was also swollen; Rash between fingers; Lymphadena; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Shoe was swollen up/swelling is in his lower left: ankle, foot, and leg), SWELLING (Pelvis was also swollen), RASH (Rash between fingers) and LYMPHADENOPATHY (Lymphadena) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history provided.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for Anticoagulant therapy, VITAMIN B COMPLEX for Supplementation therapy, VIT D [VITAMIN D NOS] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PERIPHERAL SWELLING (Shoe was swollen up/swelling is in his lower left: ankle, foot, and leg), SWELLING (Pelvis was also swollen), RASH (Rash between fingers) and LYMPHADENOPATHY (Lymphadena). The patient was treated with IBUPROFEN at a dose of 200 mg; Physical therapy (Compression bag physical therapy to reduce swelling in foot from lymphedema) for Peripheral swelling and Physical therapy (compression bag physical therapy) for Lymphadenopathy. At the time of the report, PERIPHERAL SWELLING (Shoe was swollen up/swelling is in his lower left: ankle, foot, and leg), SWELLING (Pelvis was also swollen), RASH (Rash between fingers) and LYMPHADENOPATHY (Lymphadena) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, Computerised tomogram: abnormal (abnormal) left superficial inguinal lymph node is minimally prominent, measuring up to 2.8 cm, but still maintains its normal fatty hilum.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-074901 (E2B Linked Report). This case was linked to MOD-2021-074901 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Additional information received; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074901:1st dose
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Pharyngeal swelling
Clinical narrative: swelling of throat; tongue numbness; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swelling of throat) and HYPOAESTHESIA ORAL (tongue numbness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Benadryl(diphenhydramine) allergy due to PEG), Food allergy, Milk allergy and Drug allergy (allergies to medicine).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PHARYNGEAL SWELLING (swelling of throat) and HYPOAESTHESIA ORAL (tongue numbness). On 26-Mar-2021, PHARYNGEAL SWELLING (swelling of throat) and HYPOAESTHESIA ORAL (tongue numbness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported. Treatment details were not provided. Action taken with mRNA-1273 in response to the event was unknown
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received second dose of Moderna vaccine in left arm 19 days after first dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of Moderna vaccine in left arm 19 days after first dose) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of Moderna vaccine in left arm 19 days after first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received second dose of Moderna vaccine in left arm 19 days after first dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were provided No concomitant medications were provided
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Flatulence, Headache, Hyperhidrosis
Clinical narrative: Sweating like crazy (bed was soaking wet); Felt like he had COVID-19 all over; Pain; Lot of gas; Exhausted; Chills; Had a headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas) and FATIGUE (Exhausted) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Two weeks before vaccine (tested negative prior to vaccination)).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas), FATIGUE (Exhausted), CHILLS (Chills) and HEADACHE (Had a headache). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas), FATIGUE (Exhausted), CHILLS (Chills) and HEADACHE (Had a headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pain
Clinical narrative: Sweating like crazy (bed was soaking wet); Felt like he had COVID-19 all over; Pain; Lot of gas; Exhausted; Chills; Had a headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas) and FATIGUE (Exhausted) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Two weeks before vaccine (tested negative prior to vaccination)).    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas), FATIGUE (Exhausted), CHILLS (Chills) and HEADACHE (Had a headache). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating like crazy (bed was soaking wet)), MALAISE (Felt like he had COVID-19 all over), PAIN (Pain), FLATULENCE (Lot of gas), FATIGUE (Exhausted), CHILLS (Chills) and HEADACHE (Had a headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed my second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed my second shot) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed my second shot). On 25-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed my second shot) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Illness
Clinical narrative: deathly ill"; "could not get out of bed"; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (deathly ill") and GAIT INABILITY ("could not get out of bed") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (deathly ill") and GAIT INABILITY ("could not get out of bed"). At the time of the report, ILLNESS (deathly ill") and GAIT INABILITY ("could not get out of bed") had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Pain
Clinical narrative: brain fog; body aches; headache; nausea; heavy fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included SARS-CoV-2 infection in July 2020.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue). On 07-Apr-2021 at 6:00 PM, FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided Action taken with mRNA-1273 in response to the event was unknown
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: brain fog; body aches; headache; nausea; heavy fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included SARS-CoV-2 infection in July 2020.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue). On 07-Apr-2021 at 6:00 PM, FEELING ABNORMAL (brain fog), PAIN (body aches), HEADACHE (headache), NAUSEA (nausea) and FATIGUE (heavy fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided Action taken with mRNA-1273 in response to the event was unknown
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site reaction, Vaccination site vesicles
Clinical narrative: COVID arm; red blister - left elbow; pain in the left elbow - really painful; elbow was beet red - left elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow). The patient was treated with ACETAMINOPHEN for Pain, at an unspecified dose and frequency and ANTIBIOTICS at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE VESICLES (red blister - left elbow), VACCINATION SITE PAIN (pain in the left elbow - really painful) and VACCINATION SITE ERYTHEMA (elbow was beet red - left elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This spontaneous case was reported by a non-health professional and describes the occurrence of MIGRAINE (Migraine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MIGRAINE (Migraine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-074715 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hot flush, Insomnia, Joint range of motion decreased
Clinical narrative: could not bend fingers; body aches; swollen armpit under the arm that was injected; chills; fatigue; fever; Had a hard time sleeping that night because she had hot and cold flashes; hot and cold flashes; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes), HOT FLUSH (hot and cold flashes), JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches) and SWELLING (swollen armpit under the arm that was injected) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Which lasted a month and still not feeling quite back to normal.) in November 2020.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes) and HOT FLUSH (hot and cold flashes). On 11-Apr-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches), SWELLING (swollen armpit under the arm that was injected), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever). At the time of the report, INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes), HOT FLUSH (hot and cold flashes), JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches), SWELLING (swollen armpit under the arm that was injected), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       These symptoms started 24 to 26 hours after the vaccine. concomitant product include covid medications patient used prior suspect vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Swelling
Clinical narrative: could not bend fingers; body aches; swollen armpit under the arm that was injected; chills; fatigue; fever; Had a hard time sleeping that night because she had hot and cold flashes; hot and cold flashes; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes), HOT FLUSH (hot and cold flashes), JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches) and SWELLING (swollen armpit under the arm that was injected) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Which lasted a month and still not feeling quite back to normal.) in November 2020.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes) and HOT FLUSH (hot and cold flashes). On 11-Apr-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches), SWELLING (swollen armpit under the arm that was injected), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever). At the time of the report, INSOMNIA (Had a hard time sleeping that night because she had hot and cold flashes), HOT FLUSH (hot and cold flashes), JOINT RANGE OF MOTION DECREASED (could not bend fingers), PAIN (body aches), SWELLING (swollen armpit under the arm that was injected), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       These symptoms started 24 to 26 hours after the vaccine. concomitant product include covid medications patient used prior suspect vaccine.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Heart rate
Clinical narrative: Within 5 minutes experienced dizziness for two and a half days; felt weird; This spontaneous case was reported by a health care professional and describes the occurrence of DIZZINESS (Within 5 minutes experienced dizziness for two and a half days) and FEELING ABNORMAL (felt weird) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Within 5 minutes experienced dizziness for two and a half days) and FEELING ABNORMAL (felt weird). At the time of the report, DIZZINESS (Within 5 minutes experienced dizziness for two and a half days) and FEELING ABNORMAL (felt weird) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: high (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Concomitant medications were not provided. The Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: aches; 104 degree F fever which has now degraded to a low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever). At the time of the report, PAIN (aches) and PYREXIA (104 degree F fever which has now degraded to a low-grade fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (Inconclusive) 104 degree F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Ear pain, Oral pain, Pain, Pain in extremity
Clinical narrative: she can't move the right side of her face; she can't open her mouth because it hurts; achy all over; weak; felt coming down; fever; earache; a sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (a sore arm), ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache) and REDUCED FACIAL EXPRESSION (she can't move the right side of her face) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (a sore arm). On 11-Apr-2021, the patient experienced ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache), PAIN (achy all over) and ASTHENIA (weak). On 12-Apr-2021, the patient experienced REDUCED FACIAL EXPRESSION (she can't move the right side of her face) and ORAL PAIN (she can't open her mouth because it hurts). At the time of the report, PAIN IN EXTREMITY (a sore arm), ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache), REDUCED FACIAL EXPRESSION (she can't move the right side of her face), ORAL PAIN (she can't open her mouth because it hurts), PAIN (achy all over) and ASTHENIA (weak) had not resolved. Not Provided          Treatment: Ibuprofen No concomitant medication was reported .
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Reduced facial expression
Clinical narrative: she can't move the right side of her face; she can't open her mouth because it hurts; achy all over; weak; felt coming down; fever; earache; a sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (a sore arm), ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache) and REDUCED FACIAL EXPRESSION (she can't move the right side of her face) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (a sore arm). On 11-Apr-2021, the patient experienced ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache), PAIN (achy all over) and ASTHENIA (weak). On 12-Apr-2021, the patient experienced REDUCED FACIAL EXPRESSION (she can't move the right side of her face) and ORAL PAIN (she can't open her mouth because it hurts). At the time of the report, PAIN IN EXTREMITY (a sore arm), ASTHENIA (felt coming down), PYREXIA (fever), EAR PAIN (earache), REDUCED FACIAL EXPRESSION (she can't move the right side of her face), ORAL PAIN (she can't open her mouth because it hurts), PAIN (achy all over) and ASTHENIA (weak) had not resolved. Not Provided          Treatment: Ibuprofen No concomitant medication was reported .
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Headache, Myalgia
Clinical narrative: Chest pain; Shortness of breath; Chills; Ache every part of the body even if she was touch she would shout of pain; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), DYSPNOEA (Shortness of breath), CHILLS (Chills), MYALGIA (Ache every part of the body even if she was touch she would shout of pain) and HEADACHE (Severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included VITAMIN D NOS for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Ache every part of the body even if she was touch she would shout of pain) and HEADACHE (Severe headache). On 25-Mar-2021, the patient experienced CHEST PAIN (Chest pain) and DYSPNOEA (Shortness of breath). At the time of the report, CHEST PAIN (Chest pain), DYSPNOEA (Shortness of breath), CHILLS (Chills), MYALGIA (Ache every part of the body even if she was touch she would shout of pain) and HEADACHE (Severe headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       Additional concomitant medication included unspecified medicines for high blood pressure (every day) and for stomach. On an unspecified day, the patient felt ok but not 100% well. Treatment medication was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis, Myalgia, Vaccination site pain
Clinical narrative: sweaty; tired; bone muscle in body achy; injection site hurts; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweaty), FATIGUE (tired), MYALGIA (bone muscle in body achy) and VACCINATION SITE PAIN (injection site hurts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included Migraine.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweaty), FATIGUE (tired), MYALGIA (bone muscle in body achy) and VACCINATION SITE PAIN (injection site hurts). At the time of the report, HYPERHIDROSIS (sweaty), FATIGUE (tired) and MYALGIA (bone muscle in body achy) outcome was unknown.            Concomitant medication was not provided Treatment information was not provided  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable    This case was linked to US-MODERNATX, INC.-MOD-2021-074706 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074706:CROSSLINKED WITH DOSE 1
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Musculoskeletal discomfort
Clinical narrative: Discomfort in shoulder; warm feeling in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT and FEELING HOT in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT and FEELING HOT. At the time of the report, MUSCULOSKELETAL DISCOMFORT and FEELING HOT outcome was unknown. Not Provided.          Concomitant medication was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenopia, Dysarthria, Headache, Hypoaesthesia, Migraine
Clinical narrative: migraine; headache; slurred speech; hands were numb; droopy eyes; couldn't use hands properly; This spontaneous case was reported by a consumer and describes the occurrence of DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly) and MIGRAINE (migraine) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly) and HEADACHE (headache). On an unknown date, the patient experienced MIGRAINE (migraine). At the time of the report, DYSARTHRIA (slurred speech), HYPOAESTHESIA (hands were numb), ASTHENOPIA (droopy eyes), MUSCULAR WEAKNESS (couldn't use hands properly), MIGRAINE (migraine) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.